AbbVie (ABBV) ROE US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| ROE, % | ? | 74.9% | 68.6% | 46.9% | 128.7% | -129.2% | 13.2% | |
| Changes by years, y/y, % | +40pp | -6pp | -22pp | +82pp | -258pp | |||
AbbVie. ROE, %
AbbVie. ROE, changes, pp
AbbVie (ABBV) ROE US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| ROE, % | ? | 295.4% | -2 056% | -90.4% | -129.2% | 13.2% | 13.2% | |
| Changes by years, y/y, % | +221pp | -2 135pp | -175pp | -258pp | -282pp | |||
| Changes by quarters, q/q, % | +167pp | -2 352pp | +1 966pp | -39pp | +142pp | |||